Literature DB >> 21366633

Plasma carnitine is associated with fatigue in chronic hepatitis C but not in the irritable bowel syndrome.

R Anty1, S Marjoux, S Bekri, L DeGalleani, R Dainese, E Gelsi, F Cherikh, A Tran, T Piche.   

Abstract

BACKGROUND: Fatigue is an important determinant of altered quality of life in patients affected by chronic hepatitis C or the irritable bowel syndrome (IBS). AIM: In this study, we aimed at determining the contributory role of plasma levels of leptin and carnitine on fatigue in chronic hepatitis C and IBS.
METHODS: We enrolled 81 patients with chronic hepatitis C, 42 with IBS and 44 healthy subjects. Fatigue was evaluated using the Fatigue Impact Scale questionnaire. Body composition was assessed through impedance analysis. Plasma carnitine and leptin were measured.
RESULTS: Fatigue scores were significantly more elevated in patients with chronic hepatitis C and IBS than in healthy subjects. Patients with chronic hepatitis C but not IBS, had significant lower plasma levels of total and free carnitine adjusted for fat mass compared with healthy subjects. In patients with chronic hepatitis C and not with IBS, fatigue scores were negatively correlated with plasma levels of carnitine. Levels of free carnitine were significantly and independently associated with the severity of fatigue in patients with chronic hepatitis C [OR=2.019, P=0.02, CI 95% (1.01-1.23)].
CONCLUSIONS: In patients with chronic hepatitis C, the severity of fatigue is associated with a low level of carnitine, suggesting that an oral supplementation may be effective to relieve fatigue in chronic hepatitis C. The underlying mechanism of fatigue in IBS does not seem to involve carnitine.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21366633     DOI: 10.1111/j.1365-2036.2011.04608.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Viral hepatitis: Mechanism of fatigue in patients with chronic hepatitis C involves carnitine.

Authors:  Rachel Thompson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-05       Impact factor: 46.802

Review 2.  Psychological morbidity of celiac disease: A review of the literature.

Authors:  Fabiana Zingone; Gillian L Swift; Timothy R Card; David S Sanders; Jonas F Ludvigsson; Julio C Bai
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

3.  Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection.

Authors:  Shinya Sato; Kei Moriya; Masanori Furukawa; Soichiro Saikawa; Tadashi Namisaki; Mitsuteru Kitade; Hideto Kawaratani; Kosuke Kaji; Hiroaki Takaya; Naotaka Shimozato; Yasuhiko Sawada; Kenichiro Seki; Koh Kitagawa; Takemi Akahane; Akira Mitoro; Yasushi Okura; Junichi Yamao; Hitoshi Yoshiji
Journal:  Clin Mol Hepatol       Date:  2019-02-25

4.  Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS.

Authors:  Francesco Russo; Guglielmina Chimienti; Giuseppe Riezzo; Michele Linsalata; Benedetta D'Attoma; Caterina Clemente; Antonella Orlando
Journal:  Dis Markers       Date:  2018-11-28       Impact factor: 3.434

5.  Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature review.

Authors:  Amirhossein Modabbernia; Hossein Poustchi; Reza Malekzadeh
Journal:  Hepat Mon       Date:  2013-01-07       Impact factor: 0.660

6.  Cats in Positive Energy Balance Have Lower Rates of Adipose Gain When Fed Diets Containing 188 versus 121 ppm L-Carnitine.

Authors:  M A Gooding; D L Minikhiem; A K Shoveller
Journal:  ScientificWorldJournal       Date:  2016-08-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.